Agenda

Return

C.139

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	December 8, 2020

Contra

Costa

County

Subject:

Purchase Order with Qiagen, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/08/2020

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Daniel Peddycord (925)-313-6712
cc:	L Walker M Wilhelm D Peddycord

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 8, 2020
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of Health Services Department, a blanket Purchase Order with Qiagen, Inc., in an amount not to exceed $1,000,000 to purchase QuantiFERON collection blood tubes, reagents and test kits for the period of December 1, 2020 to November 30, 2024.

FISCAL IMPACT:

100% funding is included in the Hospital Enterprise Fund I budget.

BACKGROUND:

Qiagen Inc. has been used by the Health Services Department for over ten (10) years. Qiagen provides the reagents required for use with testing instruments in our Public Health Laboratory. The reagents are necessary for specimens to be tested for tuberculosis, both active and latent infections. The QuantiFERON test is a specific blood test that detects TB antigen in the blood of patients who have been exposed to the tuberculosis organism. A positive test would alert the provider to provide treatment and alleviate disease in later years. Qiagen also produces extraction kits for SARS-CoV-2 which are used at the Public health Laboratory.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the health care system would not be able to detect TB antigen in those patients who have been exposed, resulting in higher health care cost when they develop disease in later years. The tests would then need to be conducted by outside labs at a greater cost to the County. Public Heath Lab also uses the reagents purchased from Qiagen to conduct similar testing for the Chevron Corporation which generates revenue for the Lab. Without the reagents we would not be able to conduct these tests.